Haemolytic uraemic syndrome

Drugs with this side effect as MedDRA Preferred Term

• VACV
  • Haemolytic uraemic syndrome: postmarketing
• acyclovir
  • Haemolytic uraemic syndrome
• carboplatin
  • Haemolytic uraemic syndrome
• cisplatin
  • Haemolytic uraemic syndrome
• cyclophosphamide
  • Haemolytic uraemic syndrome: postmarketing
• everolimus
  • Haemolytic uraemic syndrome
• felbamate
  • Haemolytic uraemic syndrome
• ganciclovir
  • Haemolytic uraemic syndrome: postmarketing
• gemcitabine
  • Haemolytic uraemic syndrome: postmarketing, rare, 0.3%
• ifosfamide
  • Haemolytic uraemic syndrome: postmarketing
• ketorolac
  • Haemolytic uraemic syndrome: postmarketing
• ketorolac tromethamine
  • Haemolytic uraemic syndrome: postmarketing
• mitomycin C
  • Haemolytic uraemic syndrome
• oxaliplatin
  • Haemolytic uraemic syndrome: postmarketing, rare
• paclitaxel
  • Haemolytic uraemic syndrome
• pazopanib
  • Haemolytic uraemic syndrome
• posaconazole
  • Haemolytic uraemic syndrome
• quinidine
  • Haemolytic uraemic syndrome
• rapamycin
  • Haemolytic uraemic syndrome: postmarketing
• sulfasalazine
  • Haemolytic uraemic syndrome
• tacrolimus
  • Haemolytic uraemic syndrome: postmarketing, uncommon
• v 1784
  • Haemolytic uraemic syndrome: rare